114 related articles for article (PubMed ID: 8725717)
1. The effects of dermatan sulfate at submicrogram/ml concentrations on in vitro thrombin generation.
Delorme MA; Tam AS; Xu L
Thromb Haemost; 1996 May; 75(5):747-51. PubMed ID: 8725717
[TBL] [Abstract][Full Text] [Related]
2. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA
J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
Ofosu FA
Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
[TBL] [Abstract][Full Text] [Related]
5. An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus.
Andrew M; Mitchell L; Berry L; Paes B; Delorme M; Ofosu F; Burrows R; Khambalia B
J Clin Invest; 1992 Jan; 89(1):321-6. PubMed ID: 1729278
[TBL] [Abstract][Full Text] [Related]
6. Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins.
Bendayan P; Boccalon H; Dupouy D; Boneu B
Thromb Haemost; 1994 May; 71(5):576-80. PubMed ID: 8091383
[TBL] [Abstract][Full Text] [Related]
7. Experimental studies on the relative efficacy of dermatan sulphate and heparin as antithrombotic agents.
Merton RE; Thomas DP
Thromb Haemost; 1987 Oct; 58(3):839-42. PubMed ID: 3433248
[TBL] [Abstract][Full Text] [Related]
8. Activation of heparin cofactor II by heparin and dermatan sulfate.
Tollefsen DM
Nouv Rev Fr Hematol (1978); 1984; 26(4):233-7. PubMed ID: 6548014
[TBL] [Abstract][Full Text] [Related]
9. Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding.
Vicente CP; Zancan P; Peixoto LL; Alves-Sá R; Araújo FS; Mourão PA; Pavão MS
Thromb Haemost; 2001 Nov; 86(5):1215-20. PubMed ID: 11816710
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic and anticomplementary properties of a very low molecular mass dermatan sulfate.
Fabiana Alberto M; Giaquinta Romero D; Lazzari M; Calabrese GC
Thromb Res; 2008; 122(1):109-16. PubMed ID: 17936880
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulant activity of a dermatan sulfate from the skin of the shark Scyliorhinus canicula.
Dhahri M; Mansour MB; Bertholon I; Ollivier V; Boughattas NA; Hassine M; Jandrot-Perrus M; Chaubet F; Maaroufi RM
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):547-57. PubMed ID: 20581662
[TBL] [Abstract][Full Text] [Related]
12. A simple method to measure dermatan sulfate at sub-microgram concentrations in plasma.
Dupouy D; Sié P; Dol F; Boneu B
Thromb Haemost; 1988 Oct; 60(2):236-9. PubMed ID: 3217919
[TBL] [Abstract][Full Text] [Related]
13. [Dermatan sulfate and the prevention of experimental venous thrombosis].
Desnoyers P; Bara L; Samama M
Pathol Biol (Paris); 1989 Jun; 37(6):759-67. PubMed ID: 2674877
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of thrombin inhibition by heparin cofactor II and antithrombin in the presence of the ray (Raja radula) skin dermatan sulfate.
Ben Mansour M; Dhahri M; Vénisse L; Jandrot-Perrus M; Chaubet F; Maaroufi RM
Thromb Res; 2009 Apr; 123(6):902-8. PubMed ID: 19046760
[TBL] [Abstract][Full Text] [Related]
15. The additive effect of low molecular weight heparins on thrombin inhibition by dermatan sulfate.
Cosmi B; Agnelli G; Young E; Hirsh J; Weitz J
Thromb Haemost; 1993 Sep; 70(3):443-7. PubMed ID: 8259546
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist.
Buchanan MR; Brister SJ
Thromb Res; 2000 Sep; 99(6):603-12. PubMed ID: 10974347
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic properties of a low molecular weight dermatan sulfate: comparison with unfractionated dermatan sulfate.
Dol F; Petitou M; Lormeau JC; Choay J; Caranobe C; Sie P; Saivin S; Houin G; Boneu B
J Lab Clin Med; 1990 Jan; 115(1):43-51. PubMed ID: 2299256
[TBL] [Abstract][Full Text] [Related]
19. Antithrombin activity and disaccharide composition of dermatan sulfate from different bovine tissues.
Osborne SA; Daniel RA; Desilva K; Seymour RB
Glycobiology; 2008 Mar; 18(3):225-34. PubMed ID: 18156656
[TBL] [Abstract][Full Text] [Related]
20. Modulation of heparin cofactor II activity by histidine-rich glycoprotein and platelet factor 4.
Tollefsen DM; Pestka CA
J Clin Invest; 1985 Feb; 75(2):496-501. PubMed ID: 3838317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
